254 related articles for article (PubMed ID: 22883707)
1. Interleukin-6: from an inflammatory marker to a target for inflammatory diseases.
Rincon M
Trends Immunol; 2012 Nov; 33(11):571-7. PubMed ID: 22883707
[TBL] [Abstract][Full Text] [Related]
2. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation.
Kikly K; Liu L; Na S; Sedgwick JD
Curr Opin Immunol; 2006 Dec; 18(6):670-5. PubMed ID: 17010592
[TBL] [Abstract][Full Text] [Related]
3. IL-23/IL-17 biology and therapeutic considerations.
Dong C
J Immunotoxicol; 2008 Jan; 5(1):43-6. PubMed ID: 18382857
[TBL] [Abstract][Full Text] [Related]
4. IL-6: a cytokine at the crossroads of autoimmunity.
Jones BE; Maerz MD; Buckner JH
Curr Opin Immunol; 2018 Dec; 55():9-14. PubMed ID: 30248523
[TBL] [Abstract][Full Text] [Related]
5. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the IL-6 signaling pathway: a strategy to combat chronic inflammatory diseases and cancer.
Ataie-Kachoie P; Pourgholami MH; Morris DL
Cytokine Growth Factor Rev; 2013 Apr; 24(2):163-73. PubMed ID: 23107589
[TBL] [Abstract][Full Text] [Related]
7. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
Gonzalez-Rey E; Delgado M
Curr Opin Investig Drugs; 2005 Nov; 6(11):1116-23. PubMed ID: 16312132
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy.
Kramer JM; Gaffen SL
J Periodontol; 2007 Jun; 78(6):1083-93. PubMed ID: 17539723
[TBL] [Abstract][Full Text] [Related]
9. The inflammatory Th 17 subset in immunity against self and non-self antigens.
Jin D; Zhang L; Zheng J; Zhao Y
Autoimmunity; 2008 Mar; 41(2):154-62. PubMed ID: 18324485
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
11. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage.
O'Garra A; Vieira PL; Vieira P; Goldfeld AE
J Clin Invest; 2004 Nov; 114(10):1372-8. PubMed ID: 15545984
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10: biology, role in inflammation and autoimmunity.
Lalani I; Bhol K; Ahmed AR
Ann Allergy Asthma Immunol; 1997 Dec; 79(6):469-83. PubMed ID: 9433360
[TBL] [Abstract][Full Text] [Related]
13. Chemotactic cytokines and inflammation. Biological properties of the lymphocyte and monocyte chemotactic factors ELCF, MCAF and IL-8.
Zachariae CO
Acta Derm Venereol Suppl (Stockh); 1993; 181():1-37. PubMed ID: 7901957
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 15: its role in inflammation and immunity.
Perera LP
Arch Immunol Ther Exp (Warsz); 2000; 48(6):457-64. PubMed ID: 11197599
[TBL] [Abstract][Full Text] [Related]
15. Inflammasomes and rheumatic diseases: evolving concepts.
Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
[TBL] [Abstract][Full Text] [Related]
16. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
[TBL] [Abstract][Full Text] [Related]
17. [Innate immunity, autoimmunity and autoinflammation].
Bendtzen K
Ugeskr Laeger; 2011 Sep; 173(38):2337-40. PubMed ID: 21936976
[TBL] [Abstract][Full Text] [Related]
18. Melatonin as a new possible anti-inflammatory agent.
Lissoni P; Rovelli F; Meregalli S; Fumagalli L; Musco F; Brivio F; Brivio O; Esposti G
J Biol Regul Homeost Agents; 1997; 11(4):157-9. PubMed ID: 9582617
[TBL] [Abstract][Full Text] [Related]
19. IL-21: roles in immunopathology and cancer therapy.
Søndergaard H; Skak K
Tissue Antigens; 2009 Dec; 74(6):467-79. PubMed ID: 19845910
[TBL] [Abstract][Full Text] [Related]
20. Runx1 deficiency in CD4+ T cells causes fatal autoimmune inflammatory lung disease due to spontaneous hyperactivation of cells.
Wong WF; Kohu K; Nakamura A; Ebina M; Kikuchi T; Tazawa R; Tanaka K; Kon S; Funaki T; Sugahara-Tobinai A; Looi CY; Endo S; Funayama R; Kurokawa M; Habu S; Ishii N; Fukumoto M; Nakata K; Takai T; Satake M
J Immunol; 2012 Jun; 188(11):5408-20. PubMed ID: 22551552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
